A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma.
Mornex F, Thomas L, Mohr P, Hauschild A, Delaunay MM, Lesimple T, Tilgen W, Bui BN, Guillot B, Ulrich J, Bourdin S, Mousseau M, Cupissol D, Bonneterre ME, De Gislain C, Bensadoun RJ, Clavel M.
Mornex F, et al. Among authors: bonneterre me.
Melanoma Res. 2003 Feb;13(1):97-103. doi: 10.1097/00008390-200302000-00016.
Melanoma Res. 2003.
PMID: 12569292
Clinical Trial.